Imaging News and Research

RSS

Research to help people born with 'face blindness'

A specific area in our brains is responsible for processing information about human and animal faces, both how we recognize them and how we interpret facial expressions. Now, Tel Aviv University research is exploring what makes this highly specialized part of the brain unique, a first step to finding practical applications for that information.

29 Jul 2010

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

NDS Surgical Imaging (NDSsi) today launched its next-generation visualization and informatics platform—the ConnectOR G2—with production units now shipping to customers. Based on the NDSsi technology vision of Medical Visualization Informatics (MVI), ConnectOR G2 medical-grade products are leading the industry in procedural efficacy by offering the unique ability to connect the realms of PACS imaging, surgical video and medical informatics.

29 Jul 2010

AMAG attributes increased second-quarter revenues of $18.8 million to Feraheme

AMAG Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease, today reported unaudited consolidated financial results for the second quarter and six months ended June 30, 2010. For the second quarter, AMAG reported total revenue of $18.8 million, including $16.0 million of Feraheme® (ferumoxytol) Injection for intravenous (IV) use net product revenues.

29 Jul 2010

SCCT names recipients of fourth annual Young Investigator Award

The Society of Cardiovascular Computed Tomography (SCCT), the leading international professional society dedicated to research, education and clinical excellence in cardiovascular computed tomography (CT), has named Dr. Raman Dusaj and Dr. Thomas Smith the recipients of the fourth annual Young Investigator Award. The Young Investigator Award was announced at SCCT's 2010 Annual Scientific Meeting in Las Vegas.

28 Jul 2010

Northwest Hospital surgeon performs first robotic hand surgery in America

Stacey Berner, M.D., medical director of the Hand Center at Northwest Hospital in Randallstown, MD, has become the first surgeon in America to perform a revolutionary new robotic hand surgery.

28 Jul 2010

ACS names Chemistry Nobel Laureate as winner of 2011 Priestley Medal

Ahmed H. Zewail, Ph.D., 1999 Chemistry Nobel Laureate and Linus Pauling Professor of Chemistry & Professor of Physics at the California Institute of Technology, has been named winner of the 2011 Priestley Medal by the American Chemical Society (ACS).

28 Jul 2010

CPRIT awards UH $2.4 million for new multidisciplinary research

The University of Houston (UH) received a $2.4 million grant to fund the most promising young cancer researchers who are working at the cutting-edge of a new multidisciplinary approach to fighting cancer.The award is part of the latest round of grant disbursements from the Cancer Prevention and Research Institute of Texas (CPRIT), which oversees the state's new billion-dollar war on cancer. It is UH's second CPRIT grant, and the first in the science and engineering fields.

28 Jul 2010

Scientists unveil nanoparticle for photoacoustic imaging

Spotting a single cancerous cell that has broken free from a tumor and is traveling through the bloodstream to colonize a new organ might seem like finding a needle in a haystack. But a new imaging technique from the University of Washington is a first step toward making this possible.UW researchers have developed a multifunctional nanoparticle that eliminates the background noise, enabling a more precise form of medical imaging - essentially erasing the haystack, so the needle shines through. A successful demonstration with photoacoustic imaging was reported today (July 27) in the journal Nature Communications.

28 Jul 2010

NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized prostate cancer

NYU Langone Medical Center has begun a clinical trial offering vascular-targeted photodynamic therapy to patients with localized prostate cancer. This novel, minimally invasive procedure uses a light-activated drug to deliver light energy waves by way of laser fibers in order to destroy prostate cancer cells.

28 Jul 2010

CvergenX acquires global rights to InterveneXRT technology for individualization of radiation therapy

Moffitt Cancer Center and CvergenX, Inc., announced today that they have entered into a licensing agreement under which CvergenX has acquired the exclusive worldwide rights to a technology platform that individualizes radiation therapy, InterveneXRT™. Researchers at Moffitt have used gene expression analysis and systems biology to create a radio-sensitivity classification index for individual tumors.

28 Jul 2010

NIH awards Akonni $435K to develop point-of-care diagnostics for multi-drug resistant strains of MTB

Akonni Biosystems a molecular diagnostics company focused on developing and manufacturing rapid, high multiplex solutions for infectious disease testing, today announced receipt of a $435K grant from the National Institutes of Biomedical Imaging and Bioengineering at the National Institutes of Health. The award will enable Akonni to accelerate development of its hands-free, sample-to-answer system for identifying a broader range of multi-drug resistant strains of Mycobacterium tuberculosis.

28 Jul 2010

GE Healthcare completes new $15 million medical technology manufacturing facility in Cardiff, Wales

Life sciences giant GE Healthcare has opened a $15 million medical technology manufacturing facility in Cardiff, Wales. The new facility is based at the 30-acre Maynard Centre, where the company already employs over 400 people.

28 Jul 2010

MabCure's MAbs 94% accurate in identifying ovarian cancer

Biotechnology company MabCure, Inc. today announced that a confirmatory study demonstrated the company's proprietary monoclonal antibodies (MAbs) successfully identified ovarian cancer in blood (94 percent accuracy) and with no false positives or cross-reactions with benign ovarian tumors or healthy blood. MabCure's serum diagnostic test is the first to recognize unique tumor markers or cancer fingerprints present only in ovarian cancer, the deadliest of all gynecological cancers.

28 Jul 2010

Sysmex America to debut expanded cell image analysis portfolio at AACC Annual Conference

Sysmex America, Inc., a leading medical diagnostic instrument manufacturer and information systems developer, today announced plans to debut its expanded cell image analysis portfolio during this year's American Association of Clinical Chemistry's (AACC) Annual Conference and Clinical Lab Expo July 25 - 29 in Anaheim, California.

From Sysmex America, Inc. 27 Jul 2010

Unique device helps disabled people navigate wheelchairs by sniffing

A unique device based on sniffing - inhaling and exhaling through the nose - might enable numerous disabled people to navigate wheelchairs or communicate with their loved ones. Sniffing technology might even be used in the future to create a sort of 'third hand,' to assist healthy surgeons or pilots.

27 Jul 2010

Report finds geographic variation in the use of carotid endarterectomy, carotid stenting

Medicare beneficiaries in some parts of the United States appear more likely to receive carotid endarterectomy, a surgical procedure to clear blockages in the artery supplying blood to the head, whereas those in other regions more often receive stents for the same condition, according to a report in the July 26 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Jul 2010

NCCN enters into collaboration to introduce Proventys CDS Oncology system

The National Comprehensive Cancer Network and Proventys, a leader in advanced decision support technologies, have entered into an exclusive collaboration to introduce the Proventys CDS Oncology system, a first-of-its-kind Web platform that arms oncologists with expert recommendations and evidence facilitating the delivery of high-quality, individualized patient care.

27 Jul 2010

Analogic Medical Equipment receives ISO 13485 certification and ships first MRI amplifier product

Analogic Corporation, a leading provider of medical imaging and aviation security technology, announced today that the Company's newly established China operations, Analogic Medical Equipment (Shanghai) Co., Ltd., has received ISO 13485 certification and shipped its first MRI amplifier product.

26 Jul 2010

QPS acquires Xendo Drug Development

QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, announced the completion of its acquisition of Xendo Drug Development BV (XDD), headquartered in Groningen, The Netherlands. XDD, a European contract research organization (CRO), will be known as QPS Netherlands BV and become a wholly-owned subsidiary of QPS Holdings, LLC.

26 Jul 2010

Brainlab launches ExacTrac Infrared Monitoring device for patient positioning during radiation therapy

Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.

26 Jul 2010

Imaging News and Research

Research to help people born with 'face blindness'

NDS Surgical Imaging introduces ConnectOR G2 visualization and informatics platform

AMAG attributes increased second-quarter revenues of $18.8 million to Feraheme

SCCT names recipients of fourth annual Young Investigator Award

Northwest Hospital surgeon performs first robotic hand surgery in America

ACS names Chemistry Nobel Laureate as winner of 2011 Priestley Medal

CPRIT awards UH $2.4 million for new multidisciplinary research

Scientists unveil nanoparticle for photoacoustic imaging

NYU Langone opens vascular-targeted photodynamic therapy trial to men with localized prostate cancer

CvergenX acquires global rights to InterveneXRT technology for individualization of radiation therapy

NIH awards Akonni $435K to develop point-of-care diagnostics for multi-drug resistant strains of MTB

GE Healthcare completes new $15 million medical technology manufacturing facility in Cardiff, Wales

MabCure's MAbs 94% accurate in identifying ovarian cancer

Sysmex America to debut expanded cell image analysis portfolio at AACC Annual Conference

Unique device helps disabled people navigate wheelchairs by sniffing

Report finds geographic variation in the use of carotid endarterectomy, carotid stenting

NCCN enters into collaboration to introduce Proventys CDS Oncology system

Analogic Medical Equipment receives ISO 13485 certification and ships first MRI amplifier product

QPS acquires Xendo Drug Development

Brainlab launches ExacTrac Infrared Monitoring device for patient positioning during radiation therapy

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News